Evidence map›Paper›PMID 26325181›Full record

ReviewPloS one2015

Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries.

Margaret M Demment, Karen Peters, J Andrew Dykens, Ann Dozier, Haq Nawaz, Scott McIntosh, Jennifer S Smith, Angela Sy, Tracy Irwin, Thomas T Fogg and 4 more

Abstract readReview
In one paragraph

Review in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Margaret M DemmentClinical and Translational Research Institute, University of Rochester, Rochester, New York, United States of America.
Karen PetersDivision of Community Health Sciences, University of Illinois at Chicago, Chicago, Illinois, United States of America.
J Andrew DykensDepartment of Family Medicine, University of Illinois at Chicago, Chicago, Illinois, United States of America.
Ann DozierDepartment of Public Health Sciences, University of Rochester, Rochester, New York, United States of America.
Haq NawazDepartment of Medicine, Griffin Hospital & Yale University-Griffin Prevention Research Center, New Haven, Connecticut, United States of America.
Scott McIntoshDepartment of Public Health Sciences, University of Rochester, Rochester, New York, United States of America.
Jennifer S SmithDepartment of Epidemiology, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, United States of America.
Angela SySchool of Nursing and Dental Hygiene, University of Hawai'i at Mānoa, Honolulu, Hawaii, United States of America.
Tracy IrwinDepartment of Obstetrics and Gynecology, University of Washington, Seattle, Washington, United States of America.
Thomas T FoggClinical and Translational Research Institute, University of Rochester, Rochester, New York, United States of America.
Mahmooda KhaliqDepartment of Community and Family Health, University of South Florida, Tampa, Florida, United States of America.
Rachel BlumenfeldDivision of Population Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Mehran MassoudiDivision of Population Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Timothy De Ver DyeClinical and Translational Research Institute, University of Rochester, Rochester, New York, United States of America; Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America.

Funding

Research ProjectU54CA153499 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHEN, MOON SHAO-CHUANG, CHOW, EDWARD A. · 2010 to 2015
$6.7M
Illinois Prevention Research Center: Supporting Policy and Environmental ChangeU48DP005010 · DP · UNIVERSITY OF ILLINOIS AT CHICAGO · PI POWELL, LISA · 2014 to 2018
$6.6M
Rochester Prevention Research CenterU48DP005026 · DP · UNIVERSITY OF ROCHESTER · PI BARNETT, STEVEN L · 2014 to 2018
$5.1M
Meeting Community Needs Across the Prevention SpectrumU48DP005023 · DP · YALE UNIVERSITY · PI DUFFANY, KATHLEEN O'CONNOR · 2014 to 2018
$3.9M
ACL HHS U48DP005010ACL HHS U48DP005023ACL HHS U48DP005026NCCDPHP CDC HHS 1U48DP005010-01S1NCCDPHP CDC HHS 1U48DP005023-01S1NCCDPHP CDC HHS 1U48DP005026-01S1NCI NIH HHS U54 CA153499
6 · The paper itself

Abstract

backgroundBreast and cervical cancers have emerged as major global health challenges and disproportionately lead to excess morbidity and mortality in low- and middle-income countries (LMICs) when compared to high-income countries. The objective of this paper was to highlight key findings, recommendations, and gaps in research and practice identified through a scoping study of recent reviews in breast and cervical cancer in LMICs.

methodsWe conducted a scoping study based on the six-stage framework of Arskey and O'Malley. We searched PubMed, Cochrane Reviews, and CINAHL with the following inclusion criteria: 1) published between 2005-February 2015, 2) focused on breast or cervical cancer 3) focused on LMIC, 4) review article, and 5) published in English.

resultsThrough our systematic search, 63 out of the 94 identified cervical cancer reviews met our selection criteria and 36 of the 54 in breast cancer. Cervical cancer reviews were more likely to focus upon prevention and screening, while breast cancer reviews were more likely to focus upon treatment and survivorship. Few of the breast cancer reviews referenced research and data from LMICs themselves; cervical cancer reviews were more likely to do so. Most reviews did not include elements of the PRISMA checklist.

conclusionOverall, a limited evidence base supports breast and cervical cancer control in LMICs. Further breast and cervical cancer prevention and control studies are necessary in LMICs.

Indexed as

Developing CountriesPractice Guidelines as TopicBiomedical ResearchBreast NeoplasmsEarly Detection of CancerFemaleHumansReview Literature as TopicUterine Cervical Neoplasms

Identifiers

PMID26325181
PMCPMC4556679

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.